Rosemary Murphy
Kaiser Permanente
4 Papers
40 Citations
Rosemary Murphy is an academic researcher from Kaiser Permanente. The author has contributed to research in topics: Antral follicle & Liver disease. The author has an hindex of 4, co-authored 4 publications.
Chat about Author
Papers
The Polycystic Ovary Post-Rotterdam: A Common, Age-Dependent Finding in Ovulatory Women Without Metabolic Significance
Erica Johnstone,Mitchell P. Rosen,Rebecca Neril,Deborah Trevithick,Barbara Sternfeld,Rosemary Murphy,C. Addauan-Andersen,Daniel S. McConnell,Renee A. Reijo Pera,Marcelle I. Cedars +9 more
TL;DR: In this paper, the age-specific prevalence of polycystic ovaries (PCO), as defined by the Rotterdam criteria, among normal ovulatory women, has not yet been reported.
40
Hepatic effects of lovastatin exposure in patients with liver disease: a retrospective cohort study.
Andrew L. Avins,M. Michele Manos,M. Michele Manos,Lynn Ackerson,Wei Zhao,Rosemary Murphy,Theodore R. Levin,Douglas J. Watson,Peggy Hwang,Amy Replogle,Jeffrey G. Levine +10 more
TL;DR: Exposure to lovastatin was not associated with an increased risk of adverse hepatic outcomes and the observed effects were generally consistent across a range of baseline liver-disease diagnoses and greater cumulative Lovastatin exposure was associated with fewer outcome events for some endpoints.
33
•Journal Article
Abstract 4163: Higher Dose Exposure of Lovastatin is Not Associated with Adverse Hepatic Outcomes in Patients with Existing Liver Disease
Andrew L. Avins,M Michelle Manos,Lynn Ackerson,Theodore R. Levin,Wei Zhao,Rosemary Murphy,Douglas J. Watson,Peggy Hwang,Amy Replogle,Jeffrey G. Levine +9 more
TL;DR: Among patients with liver disease, lovastatin exposure was associated with a dose-dependent reduction in the risk of several liver-disease outcomes, and these results do not support labeling recommendations for avoiding the use of lovastatin at higher doses in patients with liver disease nor the need to closely monitor LFTs during lovastatin treatment.
4
The polycystic ovary post-rotterdam: a common, age-dependent finding in ovulatory women without metabolic significance.
Erica Johnstone,Mitchell P. Rosen,Rebecca Neril,Deborah Trevithick,Barbara Sternfeld,Rosemary Murphy,C. Addauan-Andersen,Daniel S. McConnell,Renee A. Reijo Pera,Marcelle I. Cedars +9 more
TL;DR: PCO is a common, age-dependent finding among ovulatory women and these women lack the metabolic abnormalities seen in PCO syndrome, and is not an indication for metabolic evaluation.